Clinical Profile of Methotrexate-Resistant Juvenile Localized Scleroderma
January 2019
in “
Acta dermato-venereologica
”
Studysummary In this study, methotrexate effectively treated juvenile localized scleroderma in most cases, with few patients showing resistance and no identifiable profile for these resistant individuals.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on medicaljournals.se →